Rosiglitazone (trade name Avandia, GlaxoSmithKline) is an antidiabetic drug in
the thiazolidinedione class of drugs. It works as an insulin sensitizer, by binding ...
Easy to read patient leaflet for rosiglitazone. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Learn about Avandia (Rosiglitazone Maleate) may treat, uses, dosage, side
effects, drug interactions, warnings, patient labeling, reviews, and related ...
Dec 18, 2014 ... Explains the medication rosiglitazone (Avandia), a drug used for the treatment of
type II diabetes (when other diabetes drugs have failed) ...
Dec 16, 2015 ... The REMS is no longer necessary to ensure that the benefits of rosiglitazone
medicines outweigh their risks.
<sup>1,2</sup> Rosiglitazone (BRL 49653) is a prototypical TZD and has served as a
reference compound for this class. <sup>3</sup> Rosiglitazone is a potent and selective
Dec 16, 2015 ... The FDA pulls the plug on its prior risk evaluation and mitigation strategy for
rosiglitazone-containing type 2 diabetes medicines.
Jun 14, 2007 ... Rosiglitazone is widely used to treat patients with type 2 diabetes mellitus, but its
effect on cardiovascular morbidity and mortality has not been ...
Apr 8, 2016 ... Rosiglitazone is used along with a diet and exercise program and sometimes
with one or more other medications to treat type 2 diabetes ...
Sep 23, 2010 ... FDA Drug Safety Communication: Updated Risk Evaluation and Mitigation
Strategy (REMS) to Restrict Access to Rosiglitazone-containing ...